These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetics of meropenem in subjects with renal insufficiency. Leroy A; Fillastre JP; Etienne I; Borsa-Lebás F; Humbert G Eur J Clin Pharmacol; 1992; 42(5):535-8. PubMed ID: 1607000 [TBL] [Abstract][Full Text] [Related]
4. Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjects. McErlane KM; Axelson J; Vaughan R; Kerr CR; Price JD; Igwemezie L; Pillai G Eur J Clin Pharmacol; 1990; 39(4):373-6. PubMed ID: 2127569 [TBL] [Abstract][Full Text] [Related]
5. Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis. Lehmann CR; Heironimus JD; Collins CB; O'Neil TJ; Pierson WP; Crowe JT; Melikian AP; Wright GJ Clin Pharmacol Ther; 1985 Mar; 37(3):284-9. PubMed ID: 3971652 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of single doses of metoclopramide in renal failure. Bateman DN; Gokal R; Dodd TR; Blain PG Eur J Clin Pharmacol; 1981; 19(6):437-41. PubMed ID: 7250177 [TBL] [Abstract][Full Text] [Related]
7. Human erythrocyte choline uptake in uraemia: the role of intracellular substrate and an investigation into the effects of haemodialysis. Flanagan GJ; O'Kelly J; Rae C; Winearls CG; Ellory JC Clin Sci (Lond); 1996 Sep; 91(3):353-8. PubMed ID: 8869419 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis. Parasrampuria DA; Marbury T; Matsushima N; Chen S; Wickremasingha PK; He L; Dishy V; Brown KS Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930 [TBL] [Abstract][Full Text] [Related]
9. Studies on cortisol metabolism during haemodialysis in man. Deck KA; Fischer B; Hillen H Eur J Clin Invest; 1979 Jun; 9(3):203-7. PubMed ID: 113221 [TBL] [Abstract][Full Text] [Related]
10. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu. Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357 [TBL] [Abstract][Full Text] [Related]
11. Influence of first and long-term dialysis on uraemia-associated increased basal production of interleukin-1 and tumour necrosis factor alpha by circulating monocytes. Herbelin A; Ureña P; Nguyen AT; Zingraff J; Descamps-Latscha B Nephrol Dial Transplant; 1991; 6(5):349-57. PubMed ID: 1870752 [TBL] [Abstract][Full Text] [Related]
12. Effects of haemodialysis on fractional intestinal absorption of calcium in uraemia. Chanard JM; Drüeke T; Zingraff J; Man NK; Russo-Marie F; Funck-Brentano JL Eur J Clin Invest; 1976 Jun; 6(3):261-4. PubMed ID: 939248 [TBL] [Abstract][Full Text] [Related]
13. Effect of renal function and dialysis on temocillin pharmacokinetics. Boelaert J; Daneels R; Schurgers M; Mellows G; Swaisland AJ; Lambert AM; Van Landuyt HW Drugs; 1985; 29 Suppl 5():109-13. PubMed ID: 4029012 [TBL] [Abstract][Full Text] [Related]
14. Studies on kinetics of albumin in uraemic patients on chronic haemodialysis: evidence of interstitial albumin wash-down. Hildebrandt P; Jensen HA; Henriksen JH Clin Physiol; 1983 Apr; 3(2):153-62. PubMed ID: 6682736 [TBL] [Abstract][Full Text] [Related]
15. Single-dose kinetics and dosage of mecillinam in renal failure and haemodialysis. Schapira A Clin Pharmacokinet; 1984; 9(4):364-70. PubMed ID: 6088153 [TBL] [Abstract][Full Text] [Related]
16. Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation. Ibels LS; Simons LA; King JO; Williams PF; Neale FC; Stewart JH Q J Med; 1975 Oct; 44(176):601-14. PubMed ID: 1105647 [TBL] [Abstract][Full Text] [Related]
17. Exchangeable potassium content and distribution in normal subjects and uraemic patients on chronic haemodialysis. Rettori V; Gral T; Massry SG; Villamil MF Clin Sci; 1972 Jun; 42(6):673-84. PubMed ID: 5033806 [No Abstract] [Full Text] [Related]
18. Growth hormone response to acute growth hormone releasing hormone administration in uraemic patients on haemodialysis. Donnay S; García-Martín F; Martin-Escobar E; De Arriba G; Agud JL; Requejo R Nephrol Dial Transplant; 1992; 7(3):246-50. PubMed ID: 1314998 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis. Fillastre JP; Taburet AM; Fialaire A; Etienne I; Bidault R; Singlas E Drugs Exp Clin Res; 1993; 19(1):25-32. PubMed ID: 8223137 [TBL] [Abstract][Full Text] [Related]
20. Regulation of nitric oxide synthesis in uraemia. Arese M; Strasly M; Ruva C; Costamagna C; Ghigo D; MacAllister R; Verzetti G; Tetta C; Bosia A; Bussolino F Nephrol Dial Transplant; 1995; 10(8):1386-97. PubMed ID: 8538931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]